Medicare's next round of drug negotiations
The Centers for Medicare and Medicaid Services (CMS) has included Ozempic among the next 15 drugs chosen for Medicare negotiation. The CMS listed Ozempic, Rybelsus and Wegovy — all forms of semaglutide — at the top of the list of drugs for which Medicare will the negotiate the price of in 2025.
The Centers for Medicare & Medicaid Services Jan. 17 announced a record 24.2 million consumers selected health coverage ...
Final rule makes it easier for CMS to suspend agents and brokers who exchange plans without notifying the Medicare customer.
Alignment Healthcare (ALHC) challenges CMS over Medicare Star Ratings accuracy after similar cases filed by other managed care firms. Read more here.
The Centers for Medicare and Medicaid Services will issue corrected data on Medicare Advantage enrollment the week of Jan. 20 ...
As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback